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Abstract: We have comprehensively documented a case of semantic variant of primary
progressive aphasia (sv-PPA) presenting with early-onset pathological gambling (PG). While
a growing number of studies have shown the presence of behavioral alterations in patients
with sv-PPA, PG has been observed only in the behavioral variant of frontotemporal
dementia (bv-FTD). To date, no case of PG with the co-occurrence of prominent semantic
deficits at the onset of the disease has been reported in the literature. Impulse disorders at
onset may wrongly lead to a misdiagnosis (ie, psychiatric disorders). Therefore, a wider
characterization of cognitive/aphasia symptoms in patients presenting impulse disorders and
predominant language dysfunctions is recommended.
Keywords: impulse disorders, language disorders, neurodegenerative diseases, semantic
dementia
Introduction
Semantic variant of primary progressive aphasia (sv-PPA), also known as “semantic
dementia”, is one of themain clinical variants of frontotemporal dementia (FTD). From
a clinical-pathological point of view, FTD degeneration is usually caused by
TAR-DNA-binding protein (TDP-43), a 43 kilodaltons that has been reported as the
underlying cause of the disease in approximately 68%–80% of subjects with sv-PPA.1
According to the current diagnostic criteria,2 in order to identify patients with sv-PPA,
two core features are necessary: the impaired naming of objects more than actions and
impaired single-word comprehension. Moreover, several studies have demonstrated
that the clinical features of sv-PPA may depend on the atrophy prevalently involved in
the left hemisphere rather than in the right one.3 For example, severe anomia and
impaired single-word difficulties are more likely to be present in patients with a
prevalently left hemisphere involvement,4 while impaired recognition of familiar and
famous faces is a typical consequence of predominantly right hemisphere atrophy.5
There is growing awareness of the presence of behavioral alterations in patients with
sv-PPA. The most frequent clinical features are disinhibition, impulsivity, bizarre food
choices/hyperphagia and repetitive/compulsive behavior that belong to the sphere of
positive symptoms.6,7 To date, impulse control disorder or, more specifically, patholo-
gical gambling (PG) has been widely observed in the behavioral variant of FTD
(bvFTD),8,9 but no cases of PG with the co-occurrence of semantic deficits at the
onset of the disease have been reported in the literature. In this report, we describe the
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case of a 64-year-old male with symptoms of PG and the
onset of co-occurrence of semantic impairment typical of
sv-PPA.
Case report
In October 2016, an Italian-speaking, right-handed 64-year-
old male, with only eight years of formal education, was
referred to our Neurodegenerative Diseases Centre by his
family. He presented with a 2-year history of progressive
language deficits and impulse control disorders with PG
evident from the onset. Before developing PG, the patient
was described by his family as being parsimonious and care-
ful with money. Over the two years, he had started to spend
his money on gaming machines and scratch cards, squander-
ing his salary and his savings and borrowing money from
friends and relatives to continue gambling. From the onset of
the disease, the patient also presented semantic deficits and
started to use objects inappropriately because he seemed not
to recognize them. At initial neurological examination, the
patient presented with mild signs of Parkinson’s (ie, bradyki-
nesia, hypomimia) and there was a family history of dementia
(his father had Alzheimer’s disease). In the following month,
the patient underwent a neuropsychological assessment that
showed an entirely normal cognitive performance, even for
executive tasks, with the exception of a slight but not sig-
nificant impairment in verbal episodic memory that could be
related to his lexical-semantic deficits. Activities of daily
living were preserved. At the speech-language examination,
he showed isolated semantic deficits, ie, impairment in sin-
gle-word comprehension, nonverbal semantic association,
surface dyslexia and word-finding difficulties as assessed by
the Screening for Aphasia in Neurodegeneration battery
(SAND).10,11 At the spontaneous speech task, he showed a
low speech rate associatedwith several false starts and a lot of
lexical-semantic errors, ie, word-finding pauses with a ten-
dency to produce high-frequency nouns and poor content
resulting in a reduction of information units. The patient’s
linguistic profile did not report articulatory, phonetic and
phonemic errors. PG was confirmed from the Barratt
Impulsiveness Scale12 and South Oaks Gambling Screen13
(Tables 1 and 2).
MRI brain scans (3 T) showed bilateral (right > left)
fronto-temporo-insular and cingulate atrophy (Figure 1,
Panels A-B-C); SPECT brain scan showed no right temporal
lobe perfusion and hypoperfusion of the bilateral frontal
lobes and left cingulate (Figure 2) and DAT-SCAN
showed damage to the nigrostriatal dopamine system, ie
right putamen, caudate nucleus (right > left) (Figure 3).
CSF biomarkers were within the normal range for age
(Aβ1-42771 pg/mL; tTau 276 pg/mL; nd 42.79 pg/mL;
pTau181: f). Imaging and CSF biomarkers indicated a neu-
rodegenerative process that was not due to amyloidosis
(Figure 4).
The patient was diagnosed as having sv-PPA according
to the classification of Gorno-Tempini et al.2
In November 2017, the language deficit worsened to
paragrammatic speech, a low speech rate and reduction of
information content. Also, his behavioral changes increas-
ingly worsened with apathy, disinhibition, compulsive/
stereotyped behaviors and hyperphagia, as did perfor-
mance in executive/social cognition abilities, compatible
with a frontal lobe dysfunction (Tables 1 and 2).
This clinical picture indicated the presence of a second
phenotype, behavioral-frontotemporal dementia (bv-FTD),
according to the criteria of Rascovsky et al14 with asso-
ciated mild parkinsonism. A diagnosis of fronto-temporal
lobar degeneration (FTLD) was established according to
the Lund–Manchester criteria.15
PG was nonresponsive to pharmacological therapy (eg,
levodopa) during the course of the disease and was con-
sidered a significant clinical finding within the wider spec-
trum of behavioral symptoms.
Discussion
From a clinical point of view, our patient’s behavioral and
cognitive disorders showed similar trajectories. He had bilat-
eral cerebral atrophy that resulted in the overlapping of beha-
vioral and language symptoms. Behavioral symptoms are
usually related to right hemispheric atrophy; therefore, as this
was prevalent, we should have expected more evident beha-
vioral symptoms compared to semantic deficits. However,
behavioral symptoms became more pronounced during the
course of the disease.
Other causes of neurodegenerative dementia were
excluded, for example, an atypical frontal form of
Alzheimer’s disease,16 as the patient did not show low levels
of beta-amyloid at CSF examination. At the second evalua-
tion, the patient presented with dementia, spontaneous par-
kinsonism and an altered DAT SCAN, but a diagnosis of
Lewy body dementia17 was excluded because the clinical
picture was unremarkable for two core features (hallucina-
tions and fluctuating cognition) and cognitive functions were
reasonably preserved compared to behavioral changes.
Treatment with levodopa was started only several months
after onset and therefore was not responsible for the PG.
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The clinical information collected may also lead to an
alternative, possibly even complementary, hypothesis
related to the evolution of the patient’s symptoms.
As the disease progresses, the symptoms of the different
phenotypes of FTLD can converge as an initially focal
atrophy becomes more prominent and spreads to affect
large areas in the frontal and temporal lobes. Over time,
patients manifest global cognitive impairment and motor
deficits, including parkinsonism.18 In our patient, parkinso-
nian signs were very slight at the first clinical examination
(without DAT-scan evidence), but had worsened by the
second examination (with imaging evidence). This hypoth-
esis sits well with previous studies in which early parkin-
sonism is present in 18%–20% of patients with FTLD and
is most often seen in patients with bv-FTD, while it is rarely
seen in sv-PPA, only in about 3% (for a review see19).
Table 1 Patient’s neuropsychological score and cutoff score
Test First assessment Follow up (1 year) Cutoff score
Global cognitive functioning
Mini-mental state examination 28 27 <23.8
Memory
Rey auditory verbal learning test
-Immediate recall 25 20 <28.53
-Delayed recall 6 5 <4.69
-Recognition 15 10 -
Rey recall of copy of the Rey-Osterrieth figure 21,5 16,5 <9.47
Digit span forward 6 5 <4.26
Attention & executive functions
Frontal assessment battery 14 12 <12.03
- Trial making test A 53 67 >94
- Trial making test B 158 175 >283
- Trial making test BA 105 108 >187
Digit span backward 4 4 <2.65
Stroop color and word test -time 28 24 >36.92
Stroop color and word test -errors 0 0 >4.24
Phonemic (F-A-S) 25 8 <17.35
Semantic verbal fluency 23 4 <25
Social cognition
Story-based empathy task 12 3 <8.29
Visuo-spatial abilities
Copy of the Rey-Osterrieth complex figure 30 32 <28.88
Incomplete letters-VOSP battery 17 16 <16
Impulse dyscontrol
Barratt impulsiveness scale 65 68 <69,3
South Oaks gambling screen Positive Positive -
Behavioral scales
Apathy scale 2 12 >11
Geriatric depression scale 6 11 >10
Neuropsychiatric inventory 12 34 -
Frontal behavioral inventory 10 37 -
Functional autonomy
ADL 6/6 4/6 -
IADL 7/8 3/8 -
Note: Bold scores are pathological.
Abbreviations: VOSP, Visual Object and Space Perception Battery; ADL, Activities in Daily Living; IADL, Instrumental Activities in Daily Living.
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sv-PPA with parkinsonism is not yet fully understood. One
study reported that six sv-PPA patients showed parkinson-
ism, but their clinical features were not defined in detail.20
Therefore, the case could be made for a patient with bv-
FTD and prominent semantic involvement. The parkinson-
ism seen in bv-FTD patients is usually characterized by
akinetic rigid syndrome,21 the same kind that we found in
our patient. Moreover, specific patterns of cortical and sub-
cortical atrophy in the frontal lobe, insula and anterior
cingulate cortex characterize bv-FTD.22,23 Our findings in
this patient with parkinsonism show a neurodegenerative
process involving not only anterior frontal areas, but also
posterior frontal regions, including M1 and the cortico-
basal, ganglia-caudate, nucleus-thalamo-cortical motor
loops that are also implied in PG behavior.24
At the onset, PG may wrongly lead to a misdiagnosis.
It is extremely important to consider several differential
diagnoses as these symptoms may overlap with other con-
ditions, ie, late-onset psychiatric disorders. Moreover, pro-
minent PG can lead to an underestimation of cognitive/
language deficits in the early phase of the disease. A wider
characterization of impulse disorders in FTLD with pre-
dominant language dysfunctions would be crucial for an
early diagnosis.
Table 2 Patient’s speech and language score and cutoff score. Bold scores are pathological
Test First assessment Follow-up (1 year) Cutoff score
Speech-Language
SAND
- Naming
- Sentence comprehension
- Single-word comprehension
- Repetition of word and nonwords
- Repetition of sentences
- Reading
- Writing
- Semantic association
- Connected speech
Token test
CAGI naming
CAGI single-word comprehension
Pyramid and Palm Tree Test
AAT repetition subtest
ENPA verbal sentence comprehension subtest
7/14
8/8
8/12
10/10
4/6
12/16
4/6
1/4
2/6
34/36
28/48
42/48
37/52
142/150
14/14
3/14
6/8
4/12
10/10
2/6
12/16
2/6
0/4
1/6
30/36
18/48
32/48
26/52
135/150
12/14
≤9.969
≤6.157
≤10.258
≤6.349
≤2.455
≤10.106
≤2.132
≤1.166
≤3
<26.25
<41.48
<47.08
<40.15
-
<11.6
Note: Bold scores are pathological.
Abbreviations: SAND, Screening for Aphasia in Neurodegeneration; AAT, Aachener Aphasie Test; ENPA, Esame Neuropsicologico per l’Afasia.
Figure 1 Neuroimaging examinations. The patient’s first MRI brain scan (3 tesla), performed about 2 years into his illness. Panel A: Sagittal FLAIR T2 image highlights the
marked frontal and cingulate atrophy. Panel B: The axial 3D FFE T1-w image shows bilateral anterior temporal lobe atrophy (right > left). Panel C: Coronal FFE 3D T1-w
image shows fronto-insular and anterior temporal cortical atrophy, mainly on the right side.
Abbreviation: MRI, magnetic resonance imaging.
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However, we are aware that our report presents some
limitations. In particular, the lack of an experimental task
in the neuropsychological examinations. Prior reports have
shown that, on a task like the Iowa Gambling Task, the
pattern of gambling in PPA is different from bv-FTD.25
The experimental task could have been useful to distin-
guish compulsion from gambling behavior.
To sum up, FTLD is a clinical-pathological syndrome
that encompasses a heterogeneous group of neurodegen-
erative disorders. The different phenotypes described may
Figure 2 SPECT brain scan shows hypoperfusion of the right temporal lobe and hypoperfusion of the bilateral frontal lobes and left cingulate.
Abbreviation: SPECT, single-photon emission computed tomography.
Figure 3 Brain Dat-scan shows damage to the nigrostriatal dopamine system, in particular a loss of dopamine neurons in the right putamen and caudate nucleus (right > left).
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have clinical and pathological characteristics that overlap,
and it is possible that isolating a phenotype can be difficult
because its borders may not be clearly evident as they may
all belong to the same clinical-pathological spectrum.
Conclusion
In conclusion, this case is pertinent because of its atypical
onset. Over the course of time, the evolution and progres-
sion of symptoms and the distributions of pathological
changes suggest an underpinning FTLD pathology. It is
worth noting that, in order to increase the accuracy of the
clinical diagnosis, appropriate and validated batteries26 are
essential since they are inexpensive and low-tech tools that
can be used in a variety of clinical settings, such as
primary, secondary or tertiary care and research studies.
Consent
Written informed consent was obtained from the
patient for publication of this case report and accom-
panying images. This case study was approved by the
institutional ethics committee of AO Pia Fondazione
Card. G. Panico.
Disclosure
The author reports no conflicts of interest in this work.
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